LPAR1 activation by LPA leads to chemoresistance and radioresistance of tumor cells by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2), multidrug resistance transporters, and anti-oxidant proteins [46,47]. Here, PROS1 is linked to neoplasm.